- Home
- / Balaxi Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Balaxi Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₹89.8
2024-10-29
Market Capitalization
₹4.6 B
2024-10-29
Revenue
₹2.9 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 136.0M | 456.3M | 2.3B | 2.8B | 3.4B | 2.4B | 2.9B | |
| Cost of goods sold | 104.7M | 335.8M | 1.7B | 2.0B | 2.0B | 1.3B | 1.7B | |
| Gross profit | 3.0K | 36.4M | 120.6M | 593.6M | 838.2M | 1.3B | 1.1B | 1.3B |
| Gross profit margin, % | 26.8% | 26.4% | 25.7% | 30.0% | 40.1% | 46.9% | 44.2% | |
| Operating expense total | 7.7M | 14.9M | 59.4M | 165.1M | 329.7M | 766.0M | 647.3M | 885.7M |
| Depreciation and amortization | 20.0K | 34.0K | 75.0K | 3.0M | 5.1M | 17.5M | 21.0M | 18.9M |
| EBITDA | (7.7M) | 21.6M | 61.2M | 428.5M | 508.5M | 581.9M | 485.2M | 406.5M |
| EBITDA margin, % | 15.9% | 13.4% | 18.5% | 18.2% | 17.3% | 20.1% | 13.9% | |
| EBIT | (7.7M) | 24.4M | 83.6M | 425.5M | 503.4M | 564.3M | 81.3M | 387.6M |
| EBIT margin, % | 18.0% | 18.3% | 18.4% | 18.0% | 16.8% | 3.4% | 13.2% | |
| Interest income | 2.0K | 18.0K | ||||||
| Interest expense | 24.0K | 478.0K | 2.7M | 7.6M | 13.8M | 27.7M | 40.1M | |
| Pre tax profit | (7.7M) | 24.4M | 88.7M | 443.3M | 545.2M | 569.2M | 20.2M | 286.7M |
| Income tax expense | 4.7M | 27.7M | 61.9M | 68.6M | 109.6M | 44.0M | 36.0M | |
| Net Income | (7.7M) | 19.7M | 61.0M | 381.4M | 476.6M | 459.6M | (23.9M) | 250.7M |